Inovio Pharmaceuticals
INO
INO
131 hedge funds and large institutions have $194M invested in Inovio Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 46 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.14% more ownership
Funds ownership: 2.76% → 2.9% (+0.14%)
26% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 46
Holders
131
Holding in Top 10
–
Calls
$6.05M
Puts
$4.61M
Top Buyers
| 1 | +$6.19M | |
| 2 | +$4.01M | |
| 3 | +$1.8M | |
| 4 |
Axa
Paris,
France
|
+$1.51M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.41M |
Top Sellers
| 1 | -$2M | |
| 2 | -$1.85M | |
| 3 | -$1.36M | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$1.33M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$1.31M |